Vincenzo De Falco

13PUBLICATIONS
38CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Liquid biopsiesAutoimmunityMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Aug 29, 2024
Overexpression of CCL-20 and CXCL-8 genes enhances tumor escape and resistance to cemiplimab, a programmed cell death protein-1 (PD-1) inhibitor, in patients with locally advanced and metastatic cutaneous squamous cell carcinoma.

Vincenzo De Falco, Stefania Napolitano, Renato Franco

|Jul 01, 2023
Panitumumab plus trifluridine/tipiracil as anti-EGFR rechallenge therapy in patients with refractory RAS wild-type metastatic colorectal cancer: Overall survival and subgroup analysis of the randomized phase II VELO trial.

Stefania Napolitano, Davide Ciardiello, Vincenzo De Falco

|Apr 13, 2023
Pretreatment Plasma Circulating Tumor DNA RAS/BRAF Mutational Status in Refractory Metastatic Colorectal Cancer Patients Who Are Candidates for Anti-EGFR Rechallenge Therapy: A Pooled Analysis of the CAVE and VELO Clinical Trials.

Davide Ciardiello, Stefania Napolitano, Vincenzo Famiglietti

|Apr 11, 2023
Antitumor Efficacy of Dual Blockade with Encorafenib + Cetuximab in Combination with Chemotherapy in Human BRAFV600E-Mutant Colorectal Cancer.

Stefania Napolitano, Melanie Woods, Hey Min Lee

|Feb 08, 2023
Real-world clinical outcome and safety of adjuvant therapy in stage III melanoma patients: Data from two Academic Italian Institutions.

Vincenzo De Falco, Gabriella Suarato, Rossella Napolitano

|Sep 01, 2022
Role of liquid biopsy for thoracic cancers immunotherapy.

Raimondo Di Liello, Flora Cimmino, Soraya Simón

Pageof 3

Frequent Collaborators

4 joint publications

Giulia Martini

3 joint publications

Emilio Francesco Giunta

3 joint publications

Pietro Paolo Vitiello

2 joint publications

Raimondo Di Liello